The Limb Salvage Center

Filter Your Results

 

News

 

European Enrollment Begins for TOBA II BTK Trial of Intact Vascular's Tack Endovascular System

July 18, 2017 -- Intact Vascular, Inc. announced that its Tack Optimized Balloon Angioplasty II Below-the-Knee (TOBA II BTK) clinical trial has commenced enrollment in Europe,…

iVascular's Angiolite BTK Sirolimus-Eluting Stent Launched in Europe

July 18, 2017 -- iVascular announced the European launch of its Angiolite BTK sirolimus-eluting stent. The device has received CE Mark approval for treating chronic and acute …

German CRITISCH Registry Evaluates Endovascular CLI Treatment Outcomes in Octogenarians

July 12, 2017 -- Online in Journal of Endovascular Therapy, Christian Uhl, MD, et al published findings from the CRITISCH study evaluating the outcomes and periprocedural risk…

LimFlow Initiates Trials of Its Percutaneous Deep Vein Arterialization System

July 11, 2017 -- LimFlow SA announced enrollment of the first patient in the United States feasibility study of the LimFlow percutaneous deep vein arterialization (pDVA) syste…

FDA Approves 6-Month Primary Endpoint for Intact Vascular's TOBA II BTK Trial

July 10, 2017 -- Intact Vascular announced that the US Food and Drug Administration (FDA) approved an investigational device exemption supplemental application to modify …

Results Published for Bio2 Medical's Angel Catheter Pivotal Study

June 29, 2017 -- Bio2 Medical announced that the results of the pivotal study for the company's Angel catheter were published by Victor F. Tapson, MD, et al online ahead o…

Royal Philips to Acquire Spectranetics Corporation

June 28, 2017 -- Royal Philips and Spectranetics Corporation announced that they have entered into a definitive merger agreement. Philips will tender offers to shareholders fo…

FDA Grants Priority Review of 10-mg Dose of Xarelto to Reduce Risk of Recurrent VTE

June 28, 2017 -- Janssen Research & Development, LLC announced that the US Food and Drug Administration (FDA) accepted for priority review a supplemental new drug applicat…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.